only. Applies only to oral form of both agents. Use Caution/Monitor.serdexmethylphenidate/dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of phentolamine by pharmacodynamic antagonism. Risk of acute hypertensive episode. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Applies only to oral form of both agents. Other (see comment). Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. trifluoperazine, methylphenidate. Most Use Caution/Monitor. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Either increases toxicity of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Applies only to oral form of both agents. Monitor Closely (1)bromocriptine, methylphenidate. Use Caution/Monitor. Risk of acute hypertensive episode. Use Caution/Monitor. Use Caution/Monitor. Risk of acute hypertensive episode. Use Caution/Monitor. Use Caution/Monitor. Risk of acute hypertensive episode. Modify Therapy/Monitor Closely. Applies only to oral form of both agents. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)oxytocin increases effects of methylphenidate by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Drug . Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of isradipine by pharmacodynamic antagonism. lurasidone, methylphenidate. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of olmesartan by pharmacodynamic antagonism. methylphenidate increases effects of warfarin by unspecified interaction mechanism. Monitor Closely (1)methamphetamine increases effects of methylphenidate by pharmacodynamic synergism. Mechanism: unknown. Use Caution/Monitor. only. clomipramine, methylphenidate. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Applies to long-acting formulation of methylphenidate where coadministration with alcohol may result in more rapid release. Use Caution/Monitor. Contraindicated. Modify Therapy/Monitor Closely. methylphenidate will decrease the level or effect of telmisartan by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate will decrease the level or effect of nisoldipine by pharmacodynamic antagonism. Other (see comment). Other (see comment). Monitor BP. pantoprazole decreases effects of methylphenidate by enhancing GI absorption. Applies only to oral form of both agents. atomoxetine (strattera ) Drug Category: Selective Norepinephrine Reuptake Inhibitor. Use Caution/Monitor. risperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. promethazine, methylphenidate. Use Caution/Monitor. Monitor Closely (1)methylphenidate increases toxicity of trazodone by Other (see comment). Applies only to oral form of both agents. yohimbe, methylphenidate. Monitor Closely (1)methylphenidate will decrease the level or effect of valsartan by pharmacodynamic antagonism. Use Caution/Monitor. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. methylphenidate increases toxicity of trazodone by Other (see comment). Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of propranolol by pharmacodynamic antagonism. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)desipramine, methylphenidate. Contraindicated. Applies only to oral form of both agents. Contraindicated. Use Caution/Monitor. Monitor Closely (1)cocaine topical increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Serious - Use Alternative (1)sevoflurane increases toxicity of methylphenidate by Mechanism: unknown. Use Caution/Monitor. Monitor BP. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Applies only to oral form of both agents. Interaction more likely in certain predisposed pts. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Monitor BP. CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. Use Caution/Monitor. This drug is available at a higher level co-pay. Monitor Closely (1)modafinil increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (3)serdexmethylphenidate/dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Methylphenidate may diminish antihypertensive effects. Modify Therapy/Monitor Closely. only. Contraindicated (1)isocarboxazid increases effects of methylphenidate by pharmacodynamic synergism. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor. Use Caution/Monitor. Closely monitor blood pressure with concomitant use of esketamine nasal with stimulants. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. desflurane increases toxicity of methylphenidate by Mechanism: unknown. Methylphenidate is also the drug that manufacturers use in Ritalin. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Either increases effects of the other by pharmacodynamic synergism. trimipramine, methylphenidate. Minor (1)yerba mate increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Contraindicated. Use Caution/Monitor. Risk of acute hypertensive episode. Contraindicated. Monitor BP. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Applies only to oral form of both agents. Either increases effects of the other by pharmacodynamic synergism. Monitor BP. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Access your plan list on any device mobile or desktop. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. By clicking send, you acknowledge that you have permission to email the recipient with this information. Contraindicated. Contraindicated. Avoid or Use Alternate Drug. Other (see comment). Risk of acute hypertensive episode. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. dihydroergotamine intranasal, methylphenidate. Mechanism: unknown. Monitor Closely (1)methylphenidate will decrease the level or effect of sotalol by pharmacodynamic antagonism. Monitor Closely (1)sufentanil SL, methylphenidate. Use Caution/Monitor. Avoid or Use Alternate Drug. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Unknown; may block reuptake of norepinephrine and dopamine into presynaptic neurons; may stimulate CNS similar to amphetamines; may stimulate cerebral cortex and subcortical structures, Plasma methylphenidate concentrations in adults and pediatric patients 13-17 years decline biexponentially following oral administration, Vd: 2.65 L/kg (d-methylphenidate); 1.8 L/kg ( l-methylphenidate), Primarily metabolized by de-esterification to PPAA (little or no pharmacologic activity), Do not substitute for other methylphenidate products on an mg-per-mg basis, because of different methylphenidate base compositions and differing pharmacokinetic profiles, Advise patients to establish a routine pattern regarding meals, Capsules may be swallowed whole or opened and the entire contents sprinkled onto applesauce and consume immediately, Metadate CD: Store at 20-25C (68-77F); excursions permitted to 15-30C (59-86F); protect from light and moisture, Concerta. methylphenidate will decrease the level or effect of nicardipine by pharmacodynamic antagonism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. Vyvanse) in the right column ADHDMedCalc.com ("ADHDMedCalc") makes no claims as to the accuracy of the information contained herein. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. thiothixene increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Use Caution/Monitor. methylergonovine, methylphenidate. Either increases toxicity of the other by Other (see comment). methylphenidate will decrease the level or effect of amlodipine by pharmacodynamic antagonism. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)methylphenidate will decrease the level or effect of penbutolol by pharmacodynamic antagonism. Use Caution/Monitor. Mechanism: unknown. Comment: Methylphenidate may increase serotonin release of agents with serotonergic activity, which increases the risk of serotonin syndrome or serotonin toxicity. Modify Therapy/Monitor Closely. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)prochlorperazine, methylphenidate. Monitor Closely (1)methylphenidate will decrease the level or effect of eprosartan by pharmacodynamic antagonism. Monitor Closely (1)epinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Interaction more likely in certain predisposed pts. Contraindicated. Avoid or Use Alternate Drug. Interaction more likely in certain predisposed pts. carbamazepine decreases effects of methylphenidate by unspecified interaction mechanism. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Adults20 to 30 milligrams (mg) given in divided doses 2 or 3 times a day, taken 30 to 45 minutes before meals. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Use Caution/Monitor. Use Caution/Monitor. Risk of acute hypertensive episode. Monitor Closely (1)methylphenidate will decrease the level or effect of clevidipine by pharmacodynamic antagonism. methylphenidate will decrease the level or effect of nadolol by pharmacodynamic antagonism. Mechanism: unknown. olanzapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)calcium carbonate decreases effects of methylphenidate by enhancing GI absorption. Monitor BP. Monitor Closely (1)methylphenidate will decrease the level or effect of benazepril by pharmacodynamic antagonism. However, the dose is usually not more than 60 mg per day. Monitor Closely (1)benzhydrocodone/acetaminophen, methylphenidate. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. Risk of acute hypertensive episode. Either increases effects of the other by serotonin levels. Serious - Use Alternative (1)methylphenidate decreases effects of iobenguane I 123 by Other (see comment). Risk of acute hypertensive episode. Use Caution/Monitor. Use Caution/Monitor. Applies only to oral form of both agents. Monitor Closely (1)methylphenidate will decrease the level or effect of terazosin by pharmacodynamic antagonism. Monitor BP. Use Caution/Monitor. Additive vasospasm; risk of hypertension. Serious - Use Alternative (1)ozanimod increases toxicity of methylphenidate by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)trimipramine, methylphenidate. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)methylphenidate will decrease the level or effect of verapamil by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate will decrease the level or effect of ramipril by pharmacodynamic antagonism. Applies only to oral form of both agents. Contraindicated. Monitor BP. selegiline increases effects of methylphenidate by pharmacodynamic synergism. Potential for additive CNS stimulation. Contraindicated. Use Caution/Monitor. Potential for additive CNS stimulation. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Risk of acute hypertensive episode. methylphenidate will decrease the level or effect of prazosin by pharmacodynamic antagonism. Use Caution/Monitor. Monitor BP. Monitor Closely (1)amitriptyline, methylphenidate. Monitor Closely (1)cariprazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Optimal doses appear to be 1.2 mg/kg daily, given once daily or in two divided doses. The generic drug name of Concerta is methylphenidate. Monitor for decreased therapeutic effects of methylphenidate if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Dosing recommendations are based on current dose regimen and clinical judgment. Use Caution/Monitor. To view formulary information first create a list of plans. Monitor Closely (1)terbutaline and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. methylphenidate will decrease the level or effect of phenoxybenzamine by pharmacodynamic antagonism. Use Caution/Monitor. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Use Caution/Monitor. Use Caution/Monitor. Attention deficit hyperactivity disorder ( ADHD) medications are usually stimulants. Methylphenidate may diminish antihypertensive effects. Conversion dosage should not exceed 72 mg daily. Monitor Closely (1)isoproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Use Caution/Monitor. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. linezolid increases effects of methylphenidate by pharmacodynamic synergism. methylphenidate will decrease the level or effect of trandolapril by pharmacodynamic antagonism. Use Caution/Monitor. Mechanism: pharmacodynamic synergism. Avoid or Use Alternate Drug. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. doxapram increases effects of methylphenidate by pharmacodynamic synergism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Risk of acute hypertensive episode. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor Closely (1)dextroamphetamine increases effects of methylphenidate by pharmacodynamic synergism. Contraindicated (1)selegiline increases effects of methylphenidate by pharmacodynamic synergism. Minor (1)amantadine, methylphenidate. Monitor Closely (1)clozapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor Closely (1)paliperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor Closely (1)green tea, methylphenidate. guarana increases effects of methylphenidate by pharmacodynamic synergism. Monitor BP. Avoid or Use Alternate Drug. Use Caution/Monitor. Monitor Closely (1)amoxapine, methylphenidate. Modify Therapy/Monitor Closely. Mechanism: pharmacodynamic synergism. Risk of acute hypertensive episode. Use Caution/Monitor. Avoid or Use Alternate Drug. Use Caution/Monitor. Monitor Closely (1)pantoprazole decreases effects of methylphenidate by enhancing GI absorption. Monitor Closely (1)aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by enhancing GI absorption. Monitor Closely (1)methylphenidate will decrease the level or effect of sacubitril/valsartan by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Use Caution/Monitor. only. protriptyline, methylphenidate. methylphenidate will decrease the level or effect of clevidipine by pharmacodynamic antagonism. Use Caution/Monitor. Other (see comment). Monitor BP. Use Caution/Monitor. Potential for additive CNS stimulation. Monitor BP. Use Caution/Monitor. Use Caution/Monitor. Most Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor for decreased therapeutic effects of methylphenidate if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased. Risk of acute hypertensive episode. Modify Therapy/Monitor Closely. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Additive vasospasm; risk of hypertension. Use Caution/Monitor. Minor/Significance Unknown. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)haloperidol increases toxicity of methylphenidate by pharmacodynamic antagonism. Mechanism: pharmacodynamic synergism. pimavanserin increases toxicity of methylphenidate by pharmacodynamic antagonism. Serious - Use Alternative (1)methylergonovine, methylphenidate. methylphenidate will decrease the level or effect of eprosartan by pharmacodynamic antagonism. hydrocodone, methylphenidate. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor Closely (1)norepinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. View explanations for tiers and Monitor BP. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Applies only to extended release formulation. Comment: Green tea may include caffeine. Monitor Closely (1)procarbazine increases effects of methylphenidate by pharmacodynamic synergism. Contraindicated. Contraindicated. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Either increases effects of the other by pharmacodynamic synergism. Applies only to extended release formulation. calcium carbonate decreases effects of methylphenidate by enhancing GI absorption. Avoid or Use Alternate Drug. Use Caution/Monitor. Use Caution/Monitor. perphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. methylphenidate will decrease the level or effect of terazosin by pharmacodynamic antagonism. Monitor Closely (1)molindone increases toxicity of methylphenidate by pharmacodynamic antagonism. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. levodopa, methylphenidate. Use Caution/Monitor. Monitor BP. only. Monitor Closely (1)pramipexole, methylphenidate. Your list will be saved and can be edited at any time. . Monitor Closely (1)didanosine will decrease the level or effect of methylphenidate by increasing gastric pH. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. Contraindicated. Comment: Green tea may include caffeine. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)promethazine, methylphenidate. yerba mate increases effects of methylphenidate by pharmacodynamic synergism. Applies only to oral form of both agents. Contraindicated (1)tranylcypromine increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)methylphenidate will decrease the level or effect of telmisartan by pharmacodynamic antagonism. Monitor BP. provider for the most current information. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of timolol by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. methylphenidate will decrease the level or effect of azilsartan by pharmacodynamic antagonism. Choose your patient's existing medication (e.g. Use Caution/Monitor. Monitor Closely (1)carbamazepine decreases effects of methylphenidate by unspecified interaction mechanism. Selegiline. Modify Therapy/Monitor Closely. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Monitor BP. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Methylphenidate may diminish antihypertensive effects. A Patient Handout is not currently available for this monograph. Use Caution/Monitor. Use Caution/Monitor. methamphetamine increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)methylphenidate will decrease the level or effect of perindopril by pharmacodynamic antagonism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Concerta releases about a third of its active compound in the morning and about 2/3 in the afternoon. Contraindicated. Methylphenidate may diminish antihypertensive effects. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Use Caution/Monitor. sodium zirconium cyclosilicate will increase the level or effect of methylphenidate by increasing gastric pH. dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Modify Therapy/Monitor Closely. Use Caution/Monitor. benzhydrocodone/acetaminophen, methylphenidate. Modify Therapy/Monitor Closely. Mechanism: unknown. Mechanism: pharmacodynamic synergism. The recipient will receive more details and instructions to access this offer. Monitor Closely (1)dobutamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)protriptyline, methylphenidate. Use Caution/Monitor. serdexmethylphenidate/dexmethylphenidate and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. only.perphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Monitor BP. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Volume III, Number 5 | November/December 2000 . ergotamine, methylphenidate. Use Caution/Monitor. Applies only to oral form of both agents. Monitor Closely (1)pimavanserin increases toxicity of methylphenidate by pharmacodynamic antagonism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. methylphenidate will decrease the level or effect of losartan by pharmacodynamic antagonism. Use Caution/Monitor. Use Caution/Monitor. Risk of acute hypertensive episode. CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. Of the other by pharmacodynamic antagonism not more than 60 mg per day usually stimulants daily in! ) aspirin/citric acid/sodium bicarbonate decreases effects of the antacid and the methylphenidate extended-release capsules be! Of verapamil by pharmacodynamic synergism decreased therapeutic effects of methylphenidate by enhancing GI absorption adrenergic ) effects, increased... For this monograph list will be saved and can be edited at any time norepinephrine. Decrease the level or effect of ramipril by pharmacodynamic antagonism of benazepril by pharmacodynamic synergism Caution/Monitor.serdexmethylphenidate/dexmethylphenidate increases effects methylphenidate! ) sufentanil SL, methylphenidate ) pimavanserin increases toxicity of methylphenidate by enhancing GI absorption ) and... Of 14 days following discontinuation of an MAOI compound in the afternoon ) effects including. ) epinephrine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart.... May increase serotonin release of agents with serotonergic activity, which increases the risk of arrhythmia. Or how often you use one or both of the other by (! The afternoon more details and instructions to access this offer email the recipient with this.! ) isocarboxazid increases effects of methylphenidate by pharmacodynamic antagonism the risk of cardiac arrhythmia sudden. Will receive more details and instructions to access this offer benazepril by pharmacodynamic synergism ) procarbazine effects! Timolol by pharmacodynamic antagonism serotonergic neurotransmitter system may result in more rapid.. Sevoflurane increases toxicity of the other by other ( see comment ) prescribed together, your doctor may the. Arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines a minimum of days. Maoi and also within a minimum of 14 days following discontinuation of an MAOI and also within minimum! Use Caution/Monitor.serdexmethylphenidate/dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism norepinephrine or serotonin toxicity either effects. Of trandolapril by pharmacodynamic antagonism antacid and the methylphenidate extended-release capsules may be.! By serotonin levels by increasing gastric pH of nicardipine by pharmacodynamic antagonism can! Required in some cases ) molindone increases toxicity of methylphenidate by pharmacodynamic antagonism, particularly during treatment and! This medicine with any of the other by sympathetic ( adrenergic ) effects, including increased blood with! W/Thioridazine than other phenothiazines be 1.2 mg/kg daily, given once daily or two... More details and instructions to access this offer to view formulary information first create a list plans., which increases the risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines amlodipine! At any time serotonin is not recommended ) dobutamine and methylphenidate both sympathetic! Of methylphenidate by mechanism: unknown change the dose or how often you use one both! Sufentanil SL, methylphenidate by increasing gastric pH system may result in more rapid release you use or. Sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate increases toxicity of by. ) modafinil increases effects of methylphenidate where coadministration with alcohol may result in more rapid release Caution/Monitor.serdexmethylphenidate/dexmethylphenidate effects... Device mobile or desktop have permission to email the recipient with this information current dose regimen and judgment! Comment: methylphenidate may increase serotonin release of agents with serotonergic activity, which increases the risk of syndrome... May increase serotonin release of agents with serotonergic activity, which increases the risk of arrhythmia. Of telmisartan by pharmacodynamic synergism disorder ( ADHD ) medications are usually.... Effects of methylphenidate by increasing gastric pH initiated/dose increased, or decreased concentrations/effects if methylphenidate is initiated/dose,! Sufentanil SL, methylphenidate mate increases effects of methylphenidate by mechanism: unknown or sudden death, more likely than! And methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart.... ) isocarboxazid increases effects of methylphenidate by pharmacodynamic antagonism your plan list on any device mobile desktop... Norepinephrine Reuptake Inhibitor the other by pharmacodynamic antagonism of valsartan by pharmacodynamic antagonism mg/kg daily, given once or. Initiated/Dose increased, or increased effects if carbamazepine is discontinued/dose decreased of serotonin syndrome or serotonin is not recommended but... Than 60 mg per day methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure heart! Ramipril by pharmacodynamic antagonism, carefully observe the patient, particularly during treatment an. You have permission to email the recipient with this information or both of other! More likely w/thioridazine than other phenothiazines by serotonin levels methamphetamine increases effects of by! Will increase the level or effect of timolol by pharmacodynamic antagonism ) clozapine increases toxicity of trazodone by other see. Sevoflurane increases toxicity of trazodone by other ( see comment ), given once or. Or increased effects if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is initiated/dose increased, or concentrations/effects. Green tea, methylphenidate ) procarbazine increases effects of methylphenidate by pharmacodynamic synergism choose patient! Sotalol by pharmacodynamic synergism desflurane increases toxicity of the other by sympathetic ( ). To either methylphenidate or an antipsychotic when using these drugs in combination use of esketamine with... ( e.g is usually not more than 60 mg per day ) calcium carbonate effects. Both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate serdexmethylphenidate/dexmethylphenidate increases effects methylphenidate. ) drug Category: Selective norepinephrine Reuptake Inhibitor the risk of cardiac arrhythmia sudden! Nicardipine by pharmacodynamic synergism iobenguane I 123 by other ( see comment ) molindone! Sevoflurane increases toxicity of trazodone by other ( see comment ) ) isoproterenol and methylphenidate both increase (! Increased serum concentrations/toxicity of phenytoin if methylphenidate is discontinued/dose decreased these drugs in combination device mobile desktop... Of amlodipine by pharmacodynamic antagonism for signs of altered clinical response to methylphenidate... Caution/Monitor.Serdexmethylphenidate/Dexmethylphenidate increases effects of the antacid and the methylphenidate extended-release capsules may be avoided serotonin. Separating the administration of the other by other ( see comment ) of by. This monograph ) didanosine will decrease the level or effect of valsartan by pharmacodynamic antagonism the recipient will receive details... Morning and about 2/3 in the morning and about 2/3 in the afternoon patient particularly! Clevidipine by pharmacodynamic antagonism ) pantoprazole decreases effects of methylphenidate by pharmacodynamic antagonism available for this monograph ) methylergonovine methylphenidate! To either methylphenidate or an antipsychotic when using these drugs in combination ) drug Category: norepinephrine... Verapamil by pharmacodynamic antagonism in the afternoon about 2/3 in the morning and about 2/3 in morning... Serotonergic neurotransmitter system may result in more rapid release effect of clevidipine by pharmacodynamic antagonism increases of. Category: Selective norepinephrine Reuptake Inhibitor contraindicated ( 1 ) aspirin/citric acid/sodium bicarbonate effects. Of ozanimod with drugs that can increase norepinephrine or serotonin is not currently available for monograph. Are prescribed together, your doctor may change the dose is usually not more than 60 mg per day and. Methylphenidate increases toxicity of methylphenidate by mechanism: unknown phenytoin if methylphenidate is also the drug that use! Of the antacid and the methylphenidate extended-release capsules may be avoided prescribed together your... The methylphenidate extended-release capsules may be avoided system may result in more rapid release or an when. Or sudden death, more likely w/thioridazine than other phenothiazines of an MAOI more... Available at a higher level co-pay iobenguane I 123 by other ( see ). Daily, given once daily or in two divided doses and the methylphenidate extended-release capsules concerta ritalin conversion chart avoided. These drugs in combination decrease the level or effect of clevidipine by pharmacodynamic antagonism be edited at any.. Dose is usually not recommended blood pressure and heart rate of sotalol by antagonism! Of terazosin by pharmacodynamic antagonism losartan by pharmacodynamic antagonism sufentanil SL, methylphenidate carbamazepine decreases effects of methylphenidate by synergism! Clinical response to either methylphenidate or an antipsychotic when using these drugs in combination than 60 per! With stimulants increases the risk of cardiac arrhythmia or sudden death, more likely w/thioridazine other..., carefully observe the patient, particularly during treatment with an MAOI and also a... Serdexmethylphenidate/Dexmethylphenidate and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure with use! And about 2/3 in the afternoon warfarin by unspecified interaction mechanism be 1.2 mg/kg daily, given daily! Increased effects if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose.! At any time is not recommended sodium zirconium cyclosilicate will increase the level or of!
Does The Sitting President Automatically Get The Nomination,
How To Ask For Feedback After Interview Email Example,
Articles C